Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21K Sell
228
-76
-25% -$7.07K ﹤0.01% 158
2026
Q1
$30K Sell
304
-43
-12% -$3.94K ﹤0.01% 143
2025
Q4
$31K Buy
347
+127
+58% +$11.6K ﹤0.01% 143
2025
Q3
$20K Sell
220
-9
-4% -$729 ﹤0.01% 168
2025
Q2
$17K Sell
229
-4
-2% -$297 ﹤0.01% 166
2025
Q1
$17K Buy
233
+181
+348% +$14.1K ﹤0.01% 168
2024
Q4
$5K Buy
+52
New +$4.55K ﹤0.01% 145

Other funds holding SRE

Clal Insurance's SRE Position: Q2 2026 in Review

Clal Insurance reduced its Sempra (SRE) stake by 25% in Q2 2026, selling an estimated $7.07K and leaving 228 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #158.

Clal Insurance first reported a position in SRE in Q4 2024 and has held it in 7 quarters since. The position peaked at $31K in Q4 2025. 1,282 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Clal Insurance held 228 shares of Sempra worth $21K as of Q2 2026.
  • Clal Insurance sold 76 Sempra shares in Q2 2026, an estimated $7.07K.
  • Sempra made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #158 holding.
  • Clal Insurance first reported a position in Sempra in Q4 2024 and has held it in 7 quarters since.
  • Clal Insurance's Sempra position peaked at $31K in Q4 2025.
  • 1,282 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.